Touizer, Emma;
(2024)
B cell and antibody responses to SARS-CoV-2 in people living with HIV.
Doctoral thesis (Ph.D), UCL (University College London).
![]() |
Text
Touizer_10191692_thesis_sig_removed.pdf Access restricted to UCL open access staff until 1 June 2025. Download (24MB) |
Abstract
People living with HIV (PLWH) have ongoing immune dysfunction despite successful antiretroviral treatment. In PLWH, B cells and antibodies phenotype, function, and development are disrupted. However, there is still no clear investigation into how this overall B cell disruption in PLWH leads to the worse serological outcomes observed in vaccination. This thesis aims to characterise the humoral and cellular response made by PLWH against a novel pathogen, SARS-CoV-2, following infection or vaccination. Participants were either recruited following SARS-CoV-2 infection (47 PLWH and 35 HIV-negative controls) or following 1, 2 or 3 doses of SARS-CoV-2 vaccines (111 PLWH and 64 HIV-negative controls). SARS-CoV-2 infection provided a sufficient stimulus so that PLWH’s binding and neutralising antibody titres were comparable to HIV-negative controls. However, following SARS-CoV-2 vaccination, PLWH’s serological output was lower compared to HIV-negative controls after each vaccine dose, regardless of previous SARS-CoV-2 infection. After the 1st vaccine dose, the neutralisation response of PLWH was delayed compared to HIV-negative controls. This delay was associated with lower frequencies of spike-specific memory B cells (MBC) and perturbed MBCs phenotype characterised by higher levels of atypical MBCs. After the 3rd vaccine dose, PLWH still had lower titres and breadth of neutralising antibodies, alongside perturbed MBCs phenotype compared to HIV- negative controls despite having similar frequencies of spike-specific MBCs. To answer if this MBC defect leads to improper recall responses in PLWH and thus inadequate affinity maturation, 10 PLWH and 10 HIV-negative individuals were chosen to sequence their bulk and antigen-specific BCR repertoire after each dose of SARS- CoV-2 vaccination. This showed that at the clonal level, PLWH’s antibody repertoire was less diverse and skewed towards aberrant somatic hypermutation. Altogether, this thesis showed that despite adequate antigenic stimulation, PLWH struggle to overcome their initial MBCs defect and thus are less able to make a successful serological response.
Type: | Thesis (Doctoral) |
---|---|
Qualification: | Ph.D |
Title: | B cell and antibody responses to SARS-CoV-2 in people living with HIV |
Language: | English |
Additional information: | Copyright © The Author 2024. Original content in this thesis is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) Licence (https://creativecommons.org/licenses/by-nc/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10191692 |
Archive Staff Only
![]() |
View Item |